Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directions

Cancer Biology and Medicine

Volumn 13, Issue 4, 2016, Pages 426-442

  Li, David ^a   Madoff, David C ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Embolization; Future liver remnant; Hepatocellular carcinoma; Hypertrophy; Liver cancer; Liver metastases; Liver regeneration; Portal vein

Indexed keywords

ABSCESS; APOPTOSIS; ARTIFICIAL EMBOLIZATION; BILIARY TRACT HEMORRHAGE; BODY SURFACE; CELL PROLIFERATION; CHEMOTHERAPY; CHOLANGITIS; CLINICAL FEATURE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FISTULA; HEMATOMA; HEMOPERITONEUM; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER CELL; LIVER HYPERTROPHY; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; OUTCOME ASSESSMENT; PARTIAL HEPATECTOMY; PNEUMOTHORAX; PORTAL VEIN EMBOLIZATION; RECANALIZATION; REVIEW; RISK FACTOR; SEPSIS; SURGICAL PATIENT; TOTAL QUALITY MANAGEMENT; TUMOR GROWTH; VEIN LIGATION;

EID: 85009887583     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.20892/j.issn.2095-3941.2016.0083     Document Type: Review

References (109)

1. Tjandra JJ, Fan ST, Wong J. Peri-operative mortality in hepatic resection. Aust N Z J Surg. 1991; 61: 201-6.
2. Tsao JI, Loftus JP, Nagorney DM, Adson MA, Ilstrup DM. Trends in morbidity and mortality of hepatic resection for malignancy. A matched comparative analysis. Ann Surg. 1994; 220: 199-205.
3. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999; 188: 304-9.
4. Aloia TA. Associating liver partition and portal vein ligation for staged hepatectomy: portal vein embolization should remain the gold standard. JAMA Surg. 2015; 150: 927-8.
5. Guiu B, Chevallier P, Denys A, Delhom E, Pierredon-Foulongne MA, Rouanet P, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016; 26: 4259-67.
6. Pandanaboyana S, Bell R, Hidalgo E, Toogood G, Prasad KR, Bartlett A, et al. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery. 2015; 157: 690-8.
7. Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008; 247: 49-57.
8. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol. 2005; 16: 779-90.
9. May BJ, Talenfeld AD, Madoff DC. Update on portal vein embolization: evidence-based outcomes, controversies, and novel strategies. J Vasc Interv Radiol. 2013; 24: 241-54.
10. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000; 127: 512-9.
11. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002; 137: 675-80; discussion 680-1.
12. Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000; 231: 480-6.
13. de Baere T, Roche A, Vavasseur D, Therasse E, Indushekar S, Elias D, et al. Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology. 1993; 188: 73-7.
14. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997; 26: 1176-81.
15. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990; 107: 521-7.
16. Nagino M, Kamiya J, Kanai M, Uesaka K, Sano T, Yamamoto H, et al. Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery. 2000; 127: 155-60.
17. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 1995; 117: 677-81.
18. Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004; 239: 722-30; discussion 730-2.
19. Koniaris LG, McKillop IH, Schwartz SI, Zimmers TA. Liver regeneration. J Am Coll Surg. 2003; 197: 634-59.
20. Black DM, Behrns KE. A scientist revisits the atrophy-hypertrophy complex: hepatic apoptosis and regeneration. Surg Oncol Clin N Am. 2002; 11: 849-64.
21. Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007; 94: 1386-94.
22. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology. 1995; 21: 434-9.
23. Starzl TE, Francavilla A, Porter KA, Benichou J, Jones AF. The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet. 1978; 147: 193-207.
24. Kock NG, Hahnloser P, Roding B, Schenk WG Jr. Interaction between portal venous and hepatic arterial blood flow: an experimental study in the dog. Surgery. 1972; 72: 414-9.
25. Michalopoulos GK, De Frances MC. Liver regeneration. Science. 1997; 276: 60-6.
26. Michalopoulos GK, Zarnegav R. Hepatocyte growth factor. Hepatology. 1992; 15: 149-55.
27. Ponfick VA. Ueber leberresection und leberreaction. Verhandl Deutsch Gesellsch Chir. 1980; 19: 28.
28. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001; 88: 165-75.
29. Goto Y, Nagino M, Nimura Y. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann Surg. 1998; 228: 209-13.
30. Duncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP. Embolization of portal vein branches induces hepatocyte replication in swine: a potential step in hepatic gene therapy. Radiology. 1999; 210: 467-77.
31. Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012; 255: 405-14.
32. Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg. 2013; 100: 388-94.
33. Matsuo K, Murakami T, Kawaguchi D, Hiroshima Y, Koda K, Yamazaki K, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization. Surgery. 2016; 159: 1289-98.
34. Eshmuminov D, Raptis DA, Linecker M, Wirsching A, Lesurtel M, Clavien PA. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br J Surg. 2016.
35. Hwang S, Ha TY, Ko GY, Kwon DI, Song GW, Jung DH, et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg. 2015; 39: 2990-8.
36. Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009; 249: 608-16.
37. Johnson TN, Tucker GT, Tanner MS, Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl. 2005; 11: 1481-93.
38. Ribero D, Chun YS, Vauthey JN. Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol. 2008; 25: 104-9.
39. Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002; 8: 233-40.
40. Soyer P, Roche A, Elias D, Levesque M. Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision making. Radiology. 1992; 184: 695-7.
41. Ribero D, Amisano M, Bertuzzo F, Langella S, Lo Tesoriere R, Ferrero A, et al. Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use? Ann Surg. 2013; 258: 801-6; discussion 806-7.
42. Leung U, Simpson AL, Araujo RLC, Gönen M, McAuliffe C, Miga MI, et al. Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure. J Am Coll Surg. 2014; 219: 620-30.
43. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013; 216: 201-9.
44. Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009; 39: 107-16.
45. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993; 9: 298-304.
46. Mihara K, Sugiura T, Okamura Y, Kanemoto H, Mizuno T, Moriguchi M, et al. A predictive factor of insufficient liver regeneration after preoperative portal vein embolization. Eur Surg Res. 2013; 51: 118-28.
47. Meier RPH, Toso C, Terraz S, Breguet R, Berney T, Andres A, et al. Improved liver function after portal vein embolization and an elective right hepatectomy. HPB (Oxford). 2015; 17: 1009-18.
48. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986; 10: 803-8.
49. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 1996; 200: 559-63.
50. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005; 16: 215-25.
51. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness-study in 26 patients. Radiology. 2003; 227: 251-60.
52. Madoff DC, Hicks ME, Vauthey JN, Charnsangavej C, Morello FA, Ahrar K, et al. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics. 2002; 22: 1063-76.
53. Di Stefano DR, de Baere T, Denys A, Hakime A, Gorin G, Gillet M, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology. 2005; 234: 625-30.
54. Kodama Y, Shimizu T, Endo H, Miyamoto N, Miyasaka K. Complications of percutaneous transhepatic portal vein embolization. J Vasc Interv Radiol. 2002; 13: 1233-7.
55. Sarwar A, Brook OR, Weinstein JL, Khwaja K, Ahmed M. Transsplenic portal vein embolization: a technique to avoid damage to the future liver remnant. Cardiovasc Intervent Radiol. 2016; 39: 1514-8.
56. Perarnau JM, Daradkeh S, Johann M, Deneuville M, Weinling P, Coniel C. Transjugular preoperative portal embolization (TJPE) a pilot study. Hepatogastroenterology. 2003; 50: 610-3.
57. Azoulay D, Raccuia JS, Castaing D, Bismuth H. Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg. 1995; 181: 266-9.
58. Denys A, Madoff DC, Doenz F, Schneider F, Gillet M, Vauthey JN, et al. Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg Oncol Clin N Am. 2002; 11: 955-68.
59. Madoff DC. Portal vein embolization: the continued search for the ideal embolic agent. J Vasc Interv Radiol. 2014; 25:1053-5.
60. Guiu B, Bize P, Gunthern D, Demartines N, Halkic N, Denys A. Portal vein embolization before right hepatectomy: improved results using n-butyl-cyanoacrylate compared to microparticles plus coils. Cardiovasc Intervent Radiol. 2013; 36: 1306-12.
61. Bent CL, Low D, Matson MB, Renfrew I, Fotheringham T. Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. Cardiovasc Intervent Radiol. 2009; 32: 471-7.
62. Fischman AM, Ward TJ, Horn JC, Kim E, Patel RS, Nowakowski FS, et al. Portal vein embolization before right hepatectomy or extended right hepatectomy using sodium tetradecyl sulfate foam: technique and initial results. J Vasc Interv Radiol. 2014; 25: 1045-53.
63. de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996; 24: 1386-91.
64. Matsuoka T, Nakatsuka H, Nakamura K, Kaminou T, Manabe T, Yamada T, et al. Long-term embolization of the portal vein with isobutyl-2-cyanoacrylate in hepatoma. Nihon Igaku Hoshasen Gakkai Zasshi. 1986; 46: 72-4.
65. Jaberi A, Toor SS, Rajan DK, Mironov O, Kachura JR, Cleary SP, et al. Comparison of clinical outcomes following glue versus polyvinyl alcohol portal vein embolization for hypertrophy of the future liver remnant prior to right hepatectomy. J Vasc Interv Radiol. 2016.
66. Cazejust J, Bessoud B, Le Bail M, Menu Y. Preoperative portal vein embolization with a combination of trisacryl microspheres, gelfoam and coils. Diagn Interv Imaging. 2015; 96: 57-64.
67. Geisel D, Malinowski M, Powerski MJ, Wüstefeld J, Heller V, Denecke T, et al. Improved hypertrophy of future remnant liver after portal vein embolization with plugs, coils and particles. Cardiovasc Intervent Radiol. 2014; 37: 1251-8.
68. Nagino M, Kanai M, Morioka A, Yamamoto H, Kawabata Y, Hayakawa N, et al. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol. 2000; 11: 1063-8.
69. Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey JN. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg. 2015; 19: 133-41; discussion 141.
70. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, et al. Is embolization of segment 4 portal veins before extended right hepatectomy justified? Surgery. 2008; 144: 744-51.
71. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC. Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol. 2008; 15: 1908-17.
72. Day RW, Conrad C, Vauthey JN, Aloia TA. Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford). 2015; 17: 936-41.
73. Capussotti L, Muratore A, Ferrero A, Anselmetti GC, Corgnier A, Regge D. Extension of right portal vein embolization to segment IV portal branches. Arch Surg. 2005; 140: 1100-3.
74. van Gulik TM, van den Esschert JW, de Graaf W, van Lienden KP, Busch ORC, Heger M, et al. Controversies in the use of portal vein embolization. Dig Surg. 2008; 25: 436-44.
75. Yeom YK, Shin JH. Complications of portal vein embolization: evaluation on cross-sectional imaging. Korean J Radiol. 2015; 16: 1079-85.
76. Angle JF, Siddiqi NH, Wallace MJ, Kundu S, Stokes L, Wojak JC, et al. Quality improvement guidelines for percutaneous transcatheter embolization: society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2010; 21: 1479-86.
77. Denys A, Bize P, Demartines N, Deschamps F, De Baere T. Quality improvement for portal vein embolization. Cardiovasc Intervent Radiol. 2010; 33: 452-6.
78. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009; 250: 540-8.
79. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003; 237: 208-17.
80. Shindoh J, Tzeng CWD, Aloia TA, Curley SA, Zimmitti G, Wei SH, et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013; 20: 2493-500.
81. Thakrar PD, Madoff DC. Preoperative portal vein embolization: an approach to improve the safety of major hepatic resection. Semin Roentgenol. 2011; 46: 142-53.
82. Benson AB 3rd, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009; 7: 350-91.
83. Palavecino M, Chun YS, Madoff DC, Zorzi D, Kishi Y, Kaseb AO, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery. 2009; 145: 399-405.
84. Azoulay D, Castaing D, Krissat J, Smail A, Marin HG, Lemoine A, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000; 232: 665-72.
85. Tanaka H, Hirohashi K, Kubo S, Shuto T, Higaki I, Kinoshita H. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg. 2000; 87: 879-82.
86. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003; 7: 1034-44.
87. Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery. 1997; 121: 135-41.
88. Al-Sharif E, Simoneau E, Hassanain M. Portal vein embolization effect on colorectal cancer liver metastasis progression: lessons learned. World J Clin Oncol. 2015; 6: 142-6.
89. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999; 86: 784-8.
90. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology. 2001; 34: 267-72.
91. Simoneau E, Aljiffry M, Salman A, Abualhassan N, Cabrera T, Valenti D, et al. Portal vein embolization stimulates tumour growth in patients with colorectal cancer liver metastases. HPB (Oxford). 2012; 14: 461-8.
92. Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011; 29: 1083-90.
93. Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg. 2011; 98: 1463-75.
94. Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg. 2007; 11: 860-8.
95. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006; 24: 2065-72.
96. Covey AM, Brown KT, Jarnagin WR, Brody LA, Schwartz L, Tuorto S, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008; 247: 451-5.
97. Simoneau E, Alanazi R, Alshenaifi J, Molla N, Aljiffry M, Medkhali A, et al. Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases. J Surg Oncol. 2016; 113: 449-55.
98. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol. 2008; 15: 2765-72.
99. Aussilhou B, Dokmak S, Faivre S, Paradis V, Vilgrain V, Belghiti J. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab. Ann Surg Oncol. 2009; 16: 1553-9.
100. Fischer C, Melstrom LG, Arnaoutakis D, Jarnagin W, Brown K, D'Angelica M, et al. Chemotherapy after portal vein embolization to protect against tumor growth during liver hypertrophy before hepatectomy. JAMA Surg. 2013; 148: 1103-8.
101. Muratore A, Zimmitti G, Ribero D, Mellano A, Viganò L, Capussotti L. Chemotherapy between the first and second stages of a two-stage hepatectomy for colorectal liver metastases: should we routinely recommend it? Ann Surg Oncol. 2012; 19: 1310-5.
102. Simoneau E, Hassanain M, Shaheen M, Aljiffry M, Molla N, Chaudhury P, et al. Portal vein embolization and its effect on tumour progression for colorectal cancer liver metastases. Br J Surg. 2015; 102: 1240-9.
103. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with preprocedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015; 17: 529-35.
104. Gruttadauria S, Luca A, Mandala L, Miraglia R, Gridelli B. Sequential preoperative ipsilateral portal and arterial embolization in patients with colorectal liver metastases. World J Surg. 2006; 30: 576-8.
105. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg. 2004; 139: 766-74.
106. Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006; 93: 1091-8.
107. am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, et al. Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective singlecenter study. Ann Surg. 2012; 255: 79-85.
108. Avritscher R, Abdelsalam ME, Javadi S, Ensor J, Wallace MJ, Alt E, et al. Percutaneous intraportal application of adipose tissuederived mesenchymal stem cells using a balloon occlusion catheter in a porcine model of liver fibrosis. J Vasc Interv Radiol. 2013; 24: 1871-8.
109. Beppu T, Nitta H, Hayashi H, Imai K, Okabe H, Nakagawa S, et al. Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial. J Gastroenterol. 2015; 50: 1197-205.